SOLESENCE, INC. — Director's Dealing 2025

Jan 13, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NANOPHASE TECHNOLOGIES Corp (NANX)
CIK: 0000883107
Period of Report: 2024-12-31

Reporting Person: JANKOWSKI JESS (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-12-31	Common Stock (right to purchase)	$2.44	A	22500	Acquired	2031-12-31	Common Stock (22500)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1000	Indirect
Common Stock	207450	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Common Stock (right to purchase)	$0.42	2026-02-23	Common Stock (69000)	69000	Direct
Common Stock (right to purchase)	$0.68	2027-02-21	Common Stock (81000)	81000	Direct
Common Stock (right to purchase)	$0.82	2028-05-23	Common Stock (90000)	90000	Direct
Common Stock (right to purchase)	$0.51	2029-05-22	Common Stock (16500)	16500	Direct
Common Stock (right to purchase)	$0.45	2027-06-18	Common Stock (90000)	90000	Direct
Common Stock (right to purchase)	$4.17	2028-12-28	Common Stock (90000)	90000	Direct
Common Stock (right to purchase)	$1.165	2029-12-20	Common Stock (72000)	72000	Direct
Common Stock (right to purchase)	$0.61	2030-12-27	Common Stock (12600)	12600	Direct

Footnotes

F1: Subject to certain restrictions, beginning on this date, options vest in three equal annual installments.